Skip to content
Open access

Early and Mid-Term Mortality After Transcatheter Aortic Valve Implantation: Five-Year Experience from the KOSUTAVI Study.

Oct 2026 · Anatolian journal of cardiology · 0 citations · 22 references
Medicine

Abstract

Background

Although transcatheter aortic valve implantation (TAVI) outcomes are well-documented, predictors of mortality beyond conventional surgical risk scores and valve-related factors in real-world, high-risk cohorts require further elucidation. This study aimed to identify the key determinants of 30-day and 1-year mortality following TAVI, with a focus on both patient-specific and procedure-specific complications.

Methods

The KOSUTAVI study is a single-center, retrospective cohort analysis of 859 consecutive high-risk individuals with severe aortic stenosis undergoing TAVI between 2020 and 2025. Primary endpoints were 30-day and 1-year all-cause mortality. Multivariate Cox regression and Kaplan-Meier analyses were used to identify independent risk factors.

Results

Mean age was 78.7 ± 6.5 years, and mean Society of Thoracic Surgeons score was 7.4 ± 2.2. The 30-day and 1-year mortality rates were 6.5% (n = 56) and 12.4% (n = 107), respectively. The 5-year all-cause mortality rate was 26.3%. In multiple Cox's analysis, chronic renal failure (hazard ratio [HR] = 7.75, P = .008, 95% CI = 1.29-16.54), presentation with cardiogenic shock (HR = 5.83, P = .028, 95% CI = 1.19-15.41), major vascular injury (HR = 22.7, P = .019, 95% CI = 1.89-45.91), and cardiac tamponade (HR = 17.9, P = .012, 95% CI = 8.13-52.62) were independently associated with 30-day mortality. While these factors were all significant in univariate analysis for 1-year mortality, they did not retain independence in the multiple model. Valve type, access route, and sex were not associated with increased mortality.

Conclusion

In a high-risk TAVI population, early mortality is predominantly driven by pre-existing renal dysfunction and acute procedural complications (shock, vascular injury, and tamponade), rather than valve-specific factors. These findings underscore the critical importance of optimizing renal function before the procedure and implementing advanced vascular protection strategies to improve early survival after TAVI.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.